Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hematologic Diseases × Specimen Handling × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Lung Neoplasms 81 Prostatic Neoplasms 73 Leukemia, Myeloid, Acute 69 Carcinoma, Non-Small-Cell Lung 60 Neoplasm Metastasis 58 Breast Neoplasms 56 Multiple Myeloma 46 Colorectal Neoplasms 44 Pancreatic Neoplasms 39 Myelodysplastic Syndromes 34 Carcinoma, Renal Cell 34 Ovarian Neoplasms 33 Melanoma 33 Triple Negative Breast Neoplasms 28 Leukemia, Lymphocytic, Chronic, B-Cell 28 Precursor Cell Lymphoblastic Leukemia-Lymphoma 27 Glioblastoma 27 Lymphoma, Large B-Cell, Diffuse 26 Urinary Bladder Neoplasms 25 Lymphoma 22 Burkitt Lymphoma 22 Squamous Cell Carcinoma of Head and Neck 21 Fallopian Tube Neoplasms 21 Glioma 20 Carcinoma, Hepatocellular 20 Brain Neoplasms 18 Mouth Neoplasms 17 Lymphoma, Non-Hodgkin 17 Leukemia, Biphenotypic, Acute 17 Endometrial Neoplasms 17

Interventions

Brentuximab Vedotin 21 Cyclophosphamide 20 fludarabine 16 Rituximab 13 Lenalidomide 13 Dexamethasone 12 fludarabine phosphate 10 Melphalan 10 Busulfan 10 Mycophenolic Acid 9 pirtobrutinib 7 dacetuzumab 7 Whole-Body Irradiation 7 Tacrolimus 7 Bortezomib 7 Doxorubicin 6 Azacitidine 6 ruxolitinib 5 Vincristine 5 Prednisone 5 Imatinib Mesylate 5 Bone Marrow Transplantation 5 ponatinib 4 pomalidomide 4 Mesna 4 Granulocyte Colony-Stimulating Factor 4 Etoposide 4 Blood Specimen Collection 4 Bendamustine Hydrochloride 4 venetoclax 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04298892 2024-07-01

INTHEMA

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Other hematologic neoplasm

Hematologic Diseases, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡